Abstract:AIM: To investigate the synergic effect of survivin antisense oligonucleotide (ASODN) combined with bcl-2 ASODN on apoptosis in lung cancer cell lines, and probe into its anti-cancer effect. METHODS ① The experiment was carried out in the immunological laboratory of Bengbu Medical College between August 2002 and April 2003. The NCI-H446 cells at logarithmic phase were divided into 6 groups: blank control group, liposomes 10 mg/L group (only blank liposomes was added), NSODN 500 nmol/L group (the first 3 groups were the control groups), survivin ASODN 500 nmol/L group, bcl-2 ASODN 5 μmol/L group, survivin ASODN 500 nmol/L +bcl-2 ASODN 5 μmol/L group (different oligonucleotides were transfected under mediation of liposomes, and then the cells were collected for the following tests). ② Under medium of liposomes, the lung cancer cell lines, NCI-H446 and SPC-A1 were transferred with survivin ASODN, and the survivin mRNA expression was detected with reverse transcription-polymerase chain reaction (RT-PCR) at 72 hours. Apoptosis index=(resting phase/DNA G1 phase)/whole cell cycle ×100%. Proliferation index=(DNA synthesis phase+G2 phase/M phase/whole cell cycle ×100%. ③ After NCI-H446 cell was treated with survivin ASODN alone or combined with bcl-2 ASODN, the cell growth inhibitory rate of NCI-H446 cell was detected with methyl-thiazol-tetrazolium (MTT) assay, and the interaction index of the two drugs was calculated, and the cell death rate was detected with trypan blue staining. ④ The analysis of variance and q test were applied in comaparing the difference of measurement data. RESULTS: ① The surviving gene expression was observed in both lung cancer cell lines. After cell line was treated with survivin ASODN, the growth inhibition and apoptosis occurred, and the survivin mRNA was obviously down-regulated, and the survivin mRNA inhibitory rates of NCI-H446 and SPC-A1 cells after treated with ASODN for 72 hours were 62.72% and 67.43% respectively. ② The results of MTT assay showed that both survivin ASODN and bcl-2 ASODN alone had the effect of growth suppression on NCI-H446 cells. The cell growth inhibitory rate of survivin ASODN combined with bcl-2 ASODN was 64.9%, was superior to that of alone application (bcl-2 ASODN alone was 34.2%) (P < 0.01), and the interaction index of the two drugs was 0.708. The trypan blue staining showed that the cell death rate in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group was 62.1%, which was higher than those of alone application (31.4% and 41.4%). The flow cytometer indicated that both survivin ASODN and bcl-2 ASODN could induce apoptosis as compared with the control groups, the apoptosis rates were 43.6% and 30.7% respectively, and it increased to 58.6% in the survivin ASODN 500 nmol/L + bcl-2 ASODN 5 μmol/L group (P < 0.01). CONCLUSION: ① Survivin ASODN can inhibit the lung cancer cell lines survivin gene expression, and induce apoptosis and growth suppression. ② Survivin ASODN combined with bcl-2 ASODN have a significant synergic anti-cancer role

Study of mechanism in growth inhibition of human lung Study of mechanism in growth inhibition of human lung adenocarcinoma with combined use of NS-398 and cisplatin

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Synergistic Effect of Gefitinib and Cisplatin on Proliferation of Lung Cancer Cell Line

Intervention Effects of Nedaplatin and Cisplatin on Proliferation and Apoptosis of Human Tumour Cells in Vitro

[Anticancer Effect of SN-38 Combined with Sorafenib on Hepatocellular Carcinoma in Vitro and Its Mechanism].

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

PI3K/mTOR inhibitor VS-5584 combined with PLK1 inhibitor exhibits synergistic anti-cancer effects on non-small cell lung cancer

Arsenic Trioxide Exerts Synergistic Effects with Cisplatin on Non-Small Cell Lung Cancer Cells Via Apoptosis Induction

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells.

Inhibition of DNA‑PK by Gefitinib Causes Synergism Between Gefitinib and Cisplatin in NSCLC

Lung Cancer Combination Treatment: Evaluation Of The Synergistic Effect Of Cisplatin Prodrug, Vinorelbine And Retinoic Acid When Co-Encapsulated In A Multi-Layered Nano-Platform

Effects of cyclooxygenase-2 inhibitor celecoxib on cyclooxygenase-2 gene expression and cisplatin chemosensitivity in human lung adenocarcinoma A549 cell line

Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells

Apoptosis of lung cancer cell lines induced by apoptosis inhibiting gene survivin antisense oligonucleotide combined with bcl-2 antisense oligonucleotide

In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines.

Effects Of Okadaic Acid Combined With Cisplatin On The Proliferation And Apoptosis Of Human Lung Adenocarcinoma A549 Cells

The Synergistic Effect of EGFR Tyrosine Kinase Inhibitor Gefitinib in Combination with Aromatase Inhibitor Anastrozole in Non-Small Cell Lung Cancer Cell Lines

Research On The Synergistic Effect Of The Nanoparticle Combined Mirna-451 And Protein On Restraining The Proliferation Of Lung Cancer Cells